BAX and central nervous system cancer: Knockdown of Cx43 using shRNA in a LN229 glioma cell line increases Bax expression, reduces co-localization of CytC with mitochondria, and conveys reduced TMZ resistance which increases tumor susceptibility to pharmaceutical treatment in vitro (Murphy et al., 2000, 2012).